Lyra Therapeutics Announces First Patient Treated in Phase 2 BEACON Clinical Trial of LYR-220 in Post-Surgical Chronic Rhinosinusitis Patients

Stock Information for Lyra Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.